Form 4: Marsh & McLennan CFO Awarded Significant Equity Grants

Marsh & McLennan's CFO, Mark C. McGivney, received significant equity awards including stock options and restricted stock units on February 24, 2026.

Summary

• Mark C. McGivney, Chief Financial Officer of Marsh & McLennan Companies, Inc. (MRSH), acquired derivative securities on February 24, 2026.
• The acquisition included 44,743 stock options with an exercise price of $176.99 per share. These options vest in four equal annual installments starting February 24, 2027, and expire on February 23, 2036.
• Additionally, 17,961 restricted stock units (RSUs) were acquired. These RSUs convert to Marsh & McLennan common stock on a 1-for-1 basis.
• The RSUs relate to performance stock units granted on February 23, 2023, for the 2023-2025 performance period, with the performance factor determined on February 24, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive alignment with shareholder interests through performance-based equity awards, which is a standard and healthy corporate governance practice.

Positives

• The equity grants align the Chief Financial Officer's interests with those of shareholders, incentivizing long-term performance.
• The vesting schedule for stock options over four years promotes sustained executive commitment.
• The conversion of performance-based RSUs indicates the achievement of previously set performance targets for the 2023-2025 period.

Negatives

• The issuance of new equity awards, particularly stock options, can lead to minor potential dilution for existing shareholders upon exercise.

Future Outlook

The equity awards, particularly the stock options with a multi-year vesting schedule, are designed to incentivize the Chief Financial Officer's future performance and long-term value creation for Marsh & McLennan.

Industry Context

StockSavvy.ai notes that executive equity compensation, such as stock options and restricted stock units, is a standard practice across the financial services and consulting industries. These awards are typically structured to align executive incentives with shareholder value creation over multi-year periods, reflecting a common approach to talent retention and performance motivation.

Comparison to Industry Standards

• The structure of these equity grants, including multi-year vesting for options and performance-based RSUs, is consistent with best practices in executive compensation within large, publicly traded companies in the financial services sector.
• For example, major competitors like Aon plc (AON) and Willis Towers Watson (WTW) frequently utilize similar long-term incentive plans to reward and retain key executives, tying a significant portion of their compensation to company performance and stock price appreciation.
• The specific exercise price of $176.99 for options is tied to the market price at grant, a common method.

Stakeholder Impact

• Shareholders: Potential for increased alignment of executive interests with shareholder value creation; minor potential for dilution from future option exercises and RSU conversions.
• Employees: Reflects the company's compensation strategy for its senior leadership.

Next Steps

• The stock options will vest in four equal annual installments on February 24th of 2027, 2028, 2029, and 2030.
• The restricted stock units will convert to common stock on a 1-for-1 basis.

Key Dates

Keywords

Marsh & McLennan, MRSH, Mark C. McGivney, Chief Financial Officer, CFO, Stock Options, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Equity Grant, Performance Stock Units, Vesting